Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FOUND: 2 - You Need To See This

Strictly’s Motsi Mabuse reveals doctor’s health warning that forced her to make changes

‘Strictly’ judge made the lifestyle changes ahead of her return to screens next month

The Independent UK

Obesity rises sharply as French Polynesia faces chronic health challenges

French Polynesia is facing growing public health pressures as rising rates of chronic disease combine with an ageing population and changing lifestyles. More than half of adult residents are now considered obese.

Radio France Internationale

Weight loss drugs give women with PMOS new hope in fight against hormonal disorder

An expanding body of research indicates that these anti-obesity drugs may also work for the disorder known as PMOS

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Chrissy Metz Loses 100 Pounds After Taking GLP-1 Meds, Despite Risks

“I know it’s not a magic wand, and I need to change other things…”

Bored Panda

Ask Fuzzy: What is diabetes and how did we learn to treat it?

Until the 1920s, Type 1 diabetes was almost a death sentence.

Newcastle Herald

Three middle-age health habits that could delay dementia for 13 years

A new study recommends people actively avert certain factors in midlife ‘as a strategy for preserving brain health’

The Independent UK

Avoiding three things in middle age ‘linked to 13 extra years without dementia’

Researchers found having normal blood pressure, no diabetes and not smoking all had a positive effect on dementia risk.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion

Eli Lilly and Co. (NYSE:LLY) stock traded higher Wednesday after the drugmaker reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by continued demand for its diabetes and obesity treatments.

Benzinga

Three Daily Servings of Full-Fat Dairy Did Not Worsen Cholesterol or Body Composition in a 12-Week Trial

A 12-week randomized trial of 74 adults found that three daily servings of full-fat dairy did not worsen blood lipids or body composition.

Medical Daily

VA Launches a Randomized Trial Testing Whether Semaglutide Can Reduce Drinking in Veterans

The VA opened enrollment in CRAVE, a placebo-controlled trial of semaglutide for alcohol use disorder in more than 600 veterans at 18 medical centers.

Medical Daily

'Floaters' do not pose a risk to your eye health

Dear Doctors: I was recently diagnosed with "floaters" in my right eye. I am told it just happens and is not my diabetes or high blood pressure. The floaters are constant and only get better with sunglasses. They make eye-involved activities difficult, and I get somewhat carsick. Any suggestions?

Bangkok Post

What Is Retatrutide? The Next-Gen GLP-1 Poised to Become the Most In-Demand Peptide

A deep dive into Retatrutide shows promise—and a lot of danger.

Marie Claire

Ultra-processed food companies hindering health drives by suing countries, says WHO

Exclusive: Director general accuses corporations of obstructing efforts to tackle obesity crisis after investigation by Guardian and others

The Guardian - UK

Employer Coverage for Weight-Loss Drugs Is Tightening for 2027, and the Summary of Benefits Is Where You Will Find Out

Large employers are narrowing GLP-1 weight-loss coverage for 2027. How to read your benefits summary and what to ask HR before open enrollment.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

The National (Scotland)

Puberty blockers trial set to proceed in England after legal challenge thrown out

A clinical trial into the benefits and risks of puberty blockers in teenagers is set to proceed after a legal challenge over the trial was thrown…

The Guardian - UK

The US public is fed up with RFK Jr. To really ‘make America healthy again’, it should look to Europe

Americans are dying younger than Europeans, despite being the wealthiest people on the planet. Wellness fads won’t change that, says public health expert Devi Sridhar

Kiplinger

GLP-1 Medicare Coverage: How to Get It for $50 (And the Catch)

A new CMS program finally brings Wegovy and Zepbound within reach for seniors. But a hidden rule about your deductible could cost you thousands.

The Guardian - UK

Black people’s risk factors for stroke ‘rising faster than for white people’

Exclusive: King’s College London analysis finds diabetes and hypertension are more common in Black African and Caribbean people

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Millions Take Metformin Daily: Here Is What New Research Says About How It Actually Works

New research suggests metformin works mainly in the gut, not the liver. Here is the plain-language explanation and why nothing about your dosing changes.

The Independent UK

Three ultra-processed foods that can be beneficial for a healthy diet

A new study has found that avoiding ultra-processed foods entirely can lead to lower diet quality

Medical Daily

Does a Packaged Food Automatically Count as Unhealthy? A Harvard Analysis Says It Is More Complicated

A Harvard analysis of 200,000 adults found diet quality predicted disease risk better than food processing level. What that means in the grocery aisle.

Medical Daily

Daily Oral Weight Loss Pill Outperformed Oral Semaglutide On Weight And Blood Sugar In Type 2 Diabetes

In a 1,698-person trial, orforglipron beat oral semaglutide on A1C and weight in type 2 diabetes. Here is what was measured and what was not.

Medical Daily

ICER Finds Weight-Loss Drugs Cost-Effective, But Analysts Warn the Projected Savings Depend on Patients Staying On Them

ICER finds GLP-1s cost-effective for obesity, but analysts warn projected savings assume patients stay on treatment. What it means for coverage.

Medical Daily

Patients Paid Less for GLP-1s While Total Spending Climbed, and Formularies Have Been Swinging Ever Since

A study found GLP-1 out-of-pocket costs fell as total spending rose. Here is what formulary swings mean for your coverage at renewal.

International Business Times UK

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

1 2 3 4 5

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.